Iconic Labs plc (GB:ICON)
LSE:ICON
Want to see GB:ICON full AI Analyst Report?
Top Page
Iconic Labs plc
(LSE:ICON)
Select Model
Select Model
Rating:40Underperform
Price Target:
1.50 p
▼(-40.00% Downside)
Action:Downgraded
Date:05/19/26
The score is driven primarily by very weak financial performance (near-zero revenue, negative equity, and negative operating cash flow), indicating elevated financial and solvency risk. Technical indicators add further pressure with a bearish trend and negative MACD, while valuation is constrained by loss-making status and no dividend support.
Positive Factors
Lean operating structure
A headcount of four implies a very lean cost base and low fixed personnel overhead. Over 2–6 months this reduces cash burn, improves flexibility to pivot or scale partnerships, and lowers the minimum revenue required to sustain basic operations compared with larger peers.
Negative Factors
Revenue collapse and persistent losses
Revenue collapsing to near zero and persistent negative EBIT indicate the core business is not producing sustainable top-line or operating profits. Over a 2–6 month horizon this undermines the ability to rebuild scale organically and increases the likelihood the company will need external capital or strategic restructuring.
Read all positive and negative factors
Positive Factors
Negative Factors
Lean operating structure
A headcount of four implies a very lean cost base and low fixed personnel overhead. Over 2–6 months this reduces cash burn, improves flexibility to pivot or scale partnerships, and lowers the minimum revenue required to sustain basic operations compared with larger peers.
Read all positive factors
Iconic Labs plc (ICON) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£214.24K
Dividend YieldN/A
Average Volume (3M)60.90K
Price to Earnings (P/E)―
Beta (1Y)-0.01
Revenue GrowthN/A
EPS Growth40.08%
CountryUK
Employees4
SectorCommunication Services
Sector Strength97
IndustryAdvertising Agencies
Share Statistics
EPS (TTM)-0.04
Shares Outstanding15,581,191
10 Day Avg. Volume30,612
30 Day Avg. Volume60,904
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.07
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Iconic Labs plc Business Overview & Revenue Model
Company Description
Iconic Labs Plc engages in media and technology business, focuses providing online marketing, and content and technology driven products. It also engages in digital and social media publishing activities. The company offers advisory services to cl...
How the Company Makes Money
null...
Iconic Labs plc Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
8
Very Negative
Cash Flow
14
Very Negative
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2023 | Jun 2022 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 26.82K | 509.17K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 26.24K | 509.10K |
| EBITDA | -589.91K | -555.12K | -246.05K | 4.77M | -759.60K | -3.10M |
| Net Income | -604.38K | -628.23K | 418.95K | 4.77M | -762.00K | -7.70M |
Balance Sheet | ||||||
| Total Assets | 13.38K | 95.04K | 139.34K | 50.24K | 6.00 | 154.06K |
| Cash, Cash Equivalents and Short-Term Investments | 8.98K | 35.74K | 129.31K | 50.24K | 5.00 | 50.93K |
| Total Debt | 3.28M | 3.08M | 2.65M | 1.94M | 2.42M | 2.42M |
| Total Liabilities | 4.25M | 4.06M | 2.86M | 3.69M | 8.94M | 8.33M |
| Stockholders Equity | -4.23M | -3.96M | -2.72M | -3.64M | -8.94M | -8.18M |
Cash Flow | ||||||
| Free Cash Flow | -192.76K | 0.00 | -802.71K | -919.76K | -50.92K | 1.15M |
| Operating Cash Flow | -344.31K | -448.07K | -802.71K | -919.76K | -50.92K | 1.15M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 304.00K | 354.50K | 881.78K | 970.00K | 0.00 | -1.28M |
Iconic Labs plc Peers Comparison
UnderperformOutperform
Sector (60)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £36.54M | 67.27 | 19.89% | 2.29% | 3.32% | -10.58% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | £2.00M | 8.95 | -3.05% | ― | 35.13% | ― | |
57 Neutral | £5.71M | -2.52 | 4.93% | ― | -8.35% | 57.48% | |
54 Neutral | £17.21M | -0.28 | -3.41% | ― | 1.84% | -1966.67% | |
40 Neutral | £409.74K | -0.02 | -114.93% | ― | -55.09% | 71.97% | |
40 Underperform | £214.24K | -0.32 | 16.45% | ― | ― | 40.08% |
* Communication Services Sector Average
GB:ICON
Iconic Labs plc
1.38
-2.38
-63.33%
GB:MDZ
Mediazest
0.10
0.04
66.67%
GB:TMG
The Mission Group
19.00
-9.00
-32.14%
GB:SYS1
System1
288.00
-148.46
-34.01%
GB:MIRI
Mirriad Advertising
0.01
>-0.01
-23.08%
GB:DNM
Dianomi Plc
19.00
-8.50
-30.91%
Iconic Labs plc Corporate Events
Private Placements and FinancingRegulatory Filings and Compliance
Iconic Labs Issues New Shares Following Convertible Note Conversion
Neutral
Apr 29, 2026
Iconic Labs plc has received a conversion notice for one of its convertible notes, resulting in the issuance of 427,323 new ordinary shares at a conversion price of £0.0117 per share, for an aggregate principal of £5,000. Application has...
Business Operations and StrategyFinancial Disclosures
Iconic Labs Warns on Going Concern as It Hunts £30m Reverse Takeover Target
Negative
Mar 31, 2026
Iconic Labs PLC reported an unaudited loss of £269,830 for the six months to 31 December 2025, slightly improved from the prior year, with total assets shrinking to £13,380 and liabilities rising to £4.25m. The board is concentratin...
Regulatory Filings and Compliance
Iconic Labs Confirms Total Voting Rights at 15.15 Million Shares
Neutral
Feb 27, 2026
Iconic Labs plc has confirmed that, as of 27 February 2026, its issued share capital comprises 15,153,868 ordinary shares of £0.0001 each, with each share carrying one voting right and no shares held in treasury. The company stated that this ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.